| Bioactivity | STING-IN-4 (Compound 1) is a STING inhibitor that inhibits STING expression and hence reducing activation of STING and nuclear factor-κB (NF-κB) signaling. STING-IN-4 shows anti-inflammatory activity and can be used for the research of sepsis[1]. |
| Target | STING |
| Invitro | STING-IN-4 (Compound 1) (20 μM; 26 h) 抑制 LPS 诱导 RAW264.7 细胞产生 NO[1]。STING-IN-4 (2.5-10 μM; 26 h) 显著抑制 RAW264.7 细胞中 iNOS 的表达[1]。STING-IN-4 (5 and 50 μM; 12 h) 在 49、52 和 55 °C时显著降低 STING 的降解,并可能与 STING 相互作用并增强 STING 的热稳定性[1]。STING-IN-4 (2.5-10 μM; 8 h) 抑制 LPS 诱导的 STING/IRF3/NF-κB 的激活[1]。 Western Blot Analysis[1] Cell Line: |
| In Vivo | STING-IN-4 (Compound 1) (1-9 mg/kg; i.p.; daily for 3 days) 保护 LPS 诱导的小鼠肝损伤,抑制脓毒症小鼠肝脏 STING/IRF3/NF-κB 激活[1]。 Animal Model: |
| Name | STING-IN-4 |
| CAS | 2250374-27-5 |
| Formula | C32H46N2O3 |
| Molar Mass | 506.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yu T, et al. Design and synthesis of hederagenin derivatives modulating STING/NF-κB signaling for the relief of acute liver injury in septic mice. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114911. |